In 56 FFPE tumor samples tested for changes in the EGFR gene, 26 had EGFR alterations (10 confirmed sequence alterations and 15 confirmed EGFR exon 19 deletions) while 30 were wildtype, resulting in a 100% PPA between the assays. The gene discussed is EGFR; the disease is neoplasm.